Seeking Alpha

WHO designates Shan5 prequalified

  • The World Health Organization extends "prequalification status" to Sanofi's (SNY +0.6%) Shan5 vaccine. This allows United Nations agencies like UNICEF to purchase the product.
  • Sanofi developed Shan5 with the Indian biotech firm Shantha. It was cleared for sale in that country in March.
  • The vaccine protects children from diptheria, tetanus, pertussis, Hib and hep B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: